Psychedelic Integration After Ceremony

People come home.

Some fly back overnight and walk into the kitchen at seven in the morning, and the kettle looks strange. Others drive home from a retreat centre two hours away and are back at their desks by Monday. Either way, there is a moment when the container closes. The circle ends, the facilitators say their goodbyes, someone hugs them, and then they are standing in an airport or a car park holding their own bag, carrying something they cannot name.

And then it is three days later, or three weeks, or three months. The extraordinary clarity is thinner than it was. Things are surfacing that nobody asked to surface. The people who love them ask how it was, and there is no sentence that is both true and sayable. Some feel, quietly and guiltily, worse than they did before they went.

This article is about that. Not about the ceremony, which is already over, but about the long, ordinary, unglamorous work that comes after it, which the psychedelic world calls integration.

It is worth being straight from the beginning about how much anyone actually knows. There is a great deal of confident advice in circulation about what a person must now do, in what order, and within what window. Much of it is sincere. Very little of it has been tested. Knowing which is which makes people harder to mislead, and it takes some pressure off, because a fair amount of what gets presented as urgent is not.

Integration is the word for the work that comes after a ceremony. Before any advice, it helps to know how little of that advice has actually been tested, and why that is freeing rather than discouraging.

Start with the word. It gets used to mean almost anything, which is part of the problem. A 2022 analysis of the concept found twenty-four different published definitions of psychedelic integration, and concluded that this profusion "has led to confusion about what integration is and how it is best practiced" [1]. That paper offered its own: integration is a process in which a person revisits and actively engages in making sense of, working through, translating, and processing the content of their experience [1].

The most useful definition came out of asking people who had actually been through it. Researchers working with a global survey of ayahuasca drinkers invited open-ended accounts of integration and received 1,630 of them. From those, they proposed integration as "a psycho-social-spiritual process of growth involving working with the learnings and challenges arising from a psychedelic experience, translating learnings into behaviours, and adjusting to changes catalysed by the experience" [2]. They call it preliminary, and they built it from ayahuasca accounts specifically. But notice what it contains that the clinical definitions often miss. It is social as well as psychological. It includes adjusting to change, not only extracting insight. And it treats the challenges as part of the material, not as a complication.

So far, so reasonable. Here is the harder part.

In 2024 a team reviewed seventy-five publications on the therapeutic frameworks used in integration sessions. That is not seventy-five trials. It was twenty-nine clinical trials plus treatment manuals, protocols, qualitative studies, reviews, books, and nineteen opinion papers. Their finding was blunt. The effects of different integration approaches on outcomes "have not been investigated by means of rigorous research," most of the available evidence "was not supported by empirical data," and while integration is regarded as crucial, "there is currently an insufficient evidence base to suggest that any type of therapy is effective for guiding integration sessions" [3]. The methodological sentence underneath that verdict is the one that matters: in all seventy-five sources, the integration process "was not compared to an alternate therapeutic modality or to a control" [3].

Nobody ran the comparison. Not once.

It gets starker. When a group of clinicians and researchers set out in 2023 to write practical integration guidelines, they first attempted a systematic review of the peer-reviewed literature. It turned up exactly one article that specifically considered psychedelic integration [4]. A 2024 paper argued that existing integration models, however thoughtful, "lack any empirical support and thus cannot be described as evidence based" [5]. A systematic review the same year found no consensus on how best to combine psychedelic experiences with established psychotherapy [6]. Another noted that despite the universal assumption that psychological support matters, "there has been surprisingly little empirical investigation of the 'psychotherapy'" in psychedelic-assisted therapy [7]. A 2026 scoping review found that measures of post-session integration remain undervalidated, and mentioned a meta-analysis that found no significant association between the number of therapy hours and treatment outcomes [8].

I checked the size of the field myself. Searching the main biomedical database for papers with "psychedelic integration" in the title or abstract returns nineteen results. The entire indexed literature on the thing people are trying to do after a retreat is smaller than the reference list of this article.

None of that means integration is pointless, and it should not be read that way.

There is one genuinely encouraging counterweight, and it deserves its place here. In 2026 a group published an observational study of fifty people who attended a psilocybin retreat and then received structured psychotherapy aimed specifically at the material that came up there. Two things stood out. Post-therapy change on their measures exceeded the change from baseline to the end of the retreat. And where one of the two therapy approaches saw participants drift back toward their starting point, the other kept improving [9]. This was not randomised, the two groups were sequential rather than randomly allocated, and the authors say only that such work "may" build on the retreat and that randomised studies are needed to confirm it [9]. But it is the closest thing available to a direct look at whether the weeks after the ceremony do anything, and it points where common sense points.

So: worth doing, no established recipe, and a lot of honest room for people to find their own way. That is the real state of things, and the rest of this article is written inside it.

Ayahuasca, psilocybin and huachuma (San Pedro) differ in some real ways, and not in some of the ways commonly claimed.

Ayahuasca, psilocybin and huachuma get discussed as though they were three flavours of the same thing. They are not, and pretending otherwise helps nobody trying to understand their own aftermath. But the differences that are real are narrower than the ones commonly claimed, so they are worth separating.

What genuinely differs is duration and format. Mescaline, the main active compound in huachuma, produces effects lasting around eleven hours, against roughly eight for LSD and about five for psilocybin, and it comes on more slowly [13]. That is not a trivial distinction. A huachuma day is roughly twice the length of a psilocybin session, usually begins in the morning, and is often spent outdoors and walking rather than lying down with eyeshades. Ayahuasca ceremonies are typically held at night, in groups, with singing, and commonly involve purging, which many participants experience as part of the medicine rather than a side effect [14]. These formats shape what people bring home. A night of ceremonies in a group leaves a shared social experience to reconcile. A long day outdoors leaves a body that walked through something.

What does not differ, as far as anyone can show, is the felt character of the experience. This surprises people. Experimental comparisons in humans found that mescaline, LSD and psilocybin produce broadly similar phenomenology, differing in onset, duration, intensity profile and physical effects rather than in kind [13]. So the common description of huachuma as gentler, more heart-centred or more grounded than ayahuasca is community lore. It may well be true. It has not been demonstrated, and the one direct comparison points the other way. This is worth saying not to flatten anyone's experience, which is theirs, but because someone told that huachuma is the gentle one, who then has a hard day with it, deserves to know they were not doing it wrong.

And the evidence base underneath huachuma is close to empty. I searched for it directly. Across the terms San Pedro, huachuma, and the botanical names, the main biomedical database indexes eighteen papers in total. Almost all are analytical chemistry, alkaloid biosynthesis, mass spectrometry and plant science, with a handful of archaeological and ethnographic pieces. Not one concerns integration. A 2026 systematic review of mescaline for psychiatric conditions screened 2,770 references, found sixty-six meeting its criteria, and judged only ten suitable for analysis, concluding that the literature "is limited and of highly variable quality, preventing definitive conclusions" [13]. Across that thin body of work it noted reports of improvement in depression measures, wellbeing, and substance use, alongside commonly reported hypertension, headache, nausea and vomiting [13].

There is also a specific trap in generalising from psilocybin. A reanalysis of five datasets covering 3,817 people found that among psychedelic-experienced users, only past psilocybin use reliably predicted nature relatedness. Not LSD, not mescaline, not ketamine or ibogaine [15]. Findings do not transfer between these compounds just because they are filed under one heading.

So when reading integration advice, including this article, it is worth noticing that the great majority of it rests on ayahuasca survey data and psilocybin trial data. Anyone who sat with huachuma is working with borrowed maps. Most of the general principles almost certainly carry across. Nobody has checked.

Why the weeks after a ceremony can feel harder than the ceremony itself, and how common that honestly is.

Here is the pattern almost nobody gets warned about.

The acute effects wear off. People come home. And then, over the following weeks, things keep arriving. Grief with no obvious trigger. Anger at someone long since forgiven. Dreams so vivid they follow a person into the morning. A memory untouched for thirty years turning up during the washing up. Waves of tenderness, then waves of something much less comfortable.

There is a name for this in the clinical literature. The unfolding process describes the continuous unravelling of insights about oneself and one's relationships after a psychedelic experience, taking place over weeks or months, in which "the manifestation and intensity of symptoms may fluctuate in waves" and, once the pharmacological effects have gone, people "may experience increased vulnerability, sadness, and anger" [26]. The concept traces to the transpersonal psychologist John Welwood, who distinguished two forms: a sequential unfolding, in which new meanings build gradually on earlier ones, and a vertical unfolding, in which something radical arrives all at once with a sense of sudden depth [26].

There is also a proposed mechanism for why the difficult version happens, and it makes intuitive sense. A model of ayahuasca's psychotherapeutic effects suggests that the strong somatic intensity "can deconstruct defense mechanisms such as dissociation and diminished interoception that are common among trauma survivors and shield them from experiencing overwhelming emotion" [27]. The same paper notes that this vivid reconnection with earlier experience is usually reported as therapeutic, but that for vulnerable people, or without adequate support, it can create difficulties or retraumatisation [27]. It is worth flagging clearly that this is a proposed model built from survey and qualitative data, not a demonstrated mechanism from a trial. Still, it describes something many people recognise: the armour came off, and nobody mentioned that they would then have to live without it for a while.

How common is this, honestly

Common. And the numbers need to be given whole, because they are usually given in halves and the halves frighten people.

In the largest survey of its kind, covering ayahuasca drinkers across more than fifty countries, 55.4% reported adverse mental health effects in the weeks or months after drinking [28]. That figure gets quoted a lot. Here is the rest of it.

The specific experiences, with the proportion of respondents reporting each: seeing or hearing things others did not, 28.5%; feeling disconnected or alone, 21.0%; nightmares or disturbing thoughts, 19.2%; anxiety, 18.9%; feeling down or hopeless, 16.6%; uncontrollable worry, 15.3%; loss of interest or pleasure, 14.8%; feeling energetically attacked, 14.9%; visual distortions, 15.1%; difficulty knowing what is real, 12.9% [28].

Read the table alongside the list. Difficulty afterwards is the majority experience, most of it is short, and the overwhelming majority of people who had it understood it as part of something worthwhile rather than as damage. About one in eight sought professional help, which is a useful number to hold for anyone wondering whether wanting support is a weakness. It is not. It puts a person in a very large group.

For psilocybin there is a smaller and differently shaped finding. In interviews with thirty people after a three-day psilocybin truffle retreat in the Netherlands, nine of them, thirty percent, raised post-experience integration challenges unprompted, in a study that was not asking about them [29]. What they described: mood fluctuations, what the researchers called post-ecstatic blues, disconnection from community, re-experiencing symptoms, spiritual bypass, and a perceived lack of support afterwards. The challenges were transient, and they co-occurred with positive after-effects including long-term remission of significant health conditions [29]. Because nobody asked, thirty percent is a floor rather than a prevalence rate.

For the minority whose difficulties do not resolve quickly, there is now real research. A mixed-methods study of 608 people who reported extended difficulties found the most common forms were anxiety and fear, existential struggle, social disconnection, and depersonalisation or derealisation [30]. In that group, about a third reported difficulties lasting over a year and about a sixth over three years [30]. That sample was recruited specifically because they had lasting problems, so those proportions describe people who already had difficulty, not psychedelic users in general. But two findings from it are worth carrying: a shorter duration was predicted by knowing what had been taken and how much, and by having had a less difficult time during the experience itself, while a narrower range of difficulties was predicted by having taken it in a guided setting [30].

The one nobody mentions

Practitioners who support people through post-psychedelic distress were surveyed about what they actually see. Twenty-eight of them, including psychiatrists, psychotherapists, integration coaches and retreat facilitators, named six recurring difficulties: existential struggle and ontological shock, anxiety and panic, problems with self-perception, dissociative symptoms, resurfacing trauma, and disappointment at unmet expectations [31].

That last one belongs in the open. A lot of people spend significant money and take significant risk hoping to be relieved of something, and come home still carrying it. The disappointment that follows is rarely spoken about, because the surrounding culture is so relentlessly positive that admitting a retreat did not fix them can feel like a confession of failure, or of not having surrendered properly, or of being uniquely broken.

The strongest practical finding in the integration research, and concrete grounding practices you can use today.

If one finding in this entire literature had to be named as the strongest practical result, it would be this one.

That is close to unanimous, in a sample of people who were genuinely struggling. It is corroborated more loosely by what the broader group of 608 reported using: meditation and prayer 27%, reading 14%, physical exercise 12%, journaling 11%, breathing practices 11%, embodied contemplative practice 10%, time in nature 10% [40].

Two caveats before any of that is taken as a prescription. These are reports of what people used, not ratings of what worked, and common activities are over-represented simply because more people do them. And none of it has been tested against a comparison. The concept analysis mentioned earlier makes a sharp observation about precisely this: integration practices are suggested in the literature "often without much rationale or context," which produces either a lack of direction or a sense of overwhelm depending on whether a person is handed too few or too many [1].

The thing about meditation

Here is a nuance absent from most integration advice, and it may save someone a difficult few weeks.

In that same interview study, meditation was reported as both helpful and unhelpful by different people, and was specifically identified as a trigger back into the psychedelic experience [33]. One participant described getting caught up in it and losing contact with the world outside her: "I was too caught up into that and then I was not experiencing the world outside of me. I got stuck in my head. But then, from that point on, I started to go outward again" [33].

Concrete grounding

A set of clinical guidelines names these specifically: bringing attention to the feet on the floor or ground, looking around and describing the immediate surroundings, a body scan, stretching, mindful walking, direct contact with nature, and self-expression through writing, singing, painting or dancing [4]. The same guidelines explicitly note that not every redirection of attention is equivalent, and that screen time is discouraged [4].

Two practices written out in full.

Sleep, food and structure

These get treated as throat-clearing before the real advice. They are not. The clinical guidelines put general recommendations about sleep, diet, stress management and screen time inside the integration model itself, not beside it [4]. The 2026 review of the subacute period lists sleep disturbance among the difficulties that can arise, and puts establishing safety and mobilising resources ahead of interpretation in the order of operations [18].

There is a gap here worth being honest about. I could find no study treating sleep at or after a retreat as a primary outcome, and no controlled trial of a classic psychedelic for insomnia. For the general wellbeing evidence often cited about nature, the most-quoted study found that people spending at least 120 minutes a week in nature reported better health and wellbeing, but it was cross-sectional, nature accounted for about one percent of the variance, and the authors themselves treat the 120-minute threshold as "a starting point for discussion" rather than a finding, partly because most people in that band reported exactly 120 minutes [41]. Time outdoors is worth having. It is not a dose.

Why an insight can be right while its urgency is not, and a simple exercise for testing a big decision.

Somewhere in the first month, many people feel an urgent clarity about a big decision. Leave the relationship. Quit the career. Sell the house. Move countries. Cut off the parent.

The proposed ayahuasca model notes that the remarkable clarity of insights can in rare cases lead to "rigid attitudes, grandiose thinking, ego inflation, narcissism, or 'spiritual narcissism'," and in other cases to "rushed major decisions such as changing career or ending a relationship, or exaggerated or unusually uninhibited behaviors" [27]. Note the "in rare cases", which is the authors' own hedge, and note that these are clinical and ethnographic observations rather than measured rates. The clinical integration model gives the practical version: the task is to help someone "evaluate the consequences of decisions that may be ultimately helpful to the patient, but impulsive in the short-term" [26].

That phrasing is exactly right, and it is the distinction to hold. Ultimately helpful but impulsive in the short term. Nobody is saying the insight is wrong. The point is that the deadline is invented.

Here is why the deadline is invented. As established earlier, there is no demonstrated human window of plasticity with an expiry date [22,24,25]. And the sense of how much one has changed runs ahead of what others can observe [45,36]. Put those together and the case for acting fast evaporates. An insight that is true in week two will still be true in week twelve. An insight that is not will have dissolved by then, sparing a great deal.

Belief change after these experiences is real and it does persist, which is precisely why care is warranted. In a prospective study of people attending ceremonies, shifts away from a strictly materialist view of reality were still present at six months, with a larger shift in people who had never used a psychedelic before [35]. Interestingly, how much someone's beliefs moved was mediated by how emotionally in sync they felt with the group, an effect that depended on their baseline tendency toward peer conformity [35]. Some of what feels like private revelation has a social component nobody noticed at the time.

An exercise: the dated decision

Small changes are a different matter. The apology can happen now. The phone call can happen now. How someone speaks to their partner can change now. The practice can begin now. The caution applies to irreversible structural decisions, not to living differently, and it would be a poor reading of this section to use it as a reason to do nothing.

What ceremony leaders say about returning, and the question worth asking before booking the next one.

At some point the thought arrives: I should go back.

Sometimes that is right. Some people work with these medicines across years in a considered way, and the returning is part of the path rather than an escape from it. Wanting to go back is not a symptom.

But it is worth knowing what the people running ceremonies say about it. In a qualitative study, ayahuasca ceremony leaders were asked about preparation and integration. On what comes after, they emphasised the importance of taking time, sharing the experience with others, and applying what was learned. They also reported that the people who kept coming back for repeated ceremonies were, in their view, the ones who were not doing the work of integrating between them [52].

That deserves to be taken seriously and held loosely, for two reasons. It is the leaders' perception, not measured outcomes. And the causal arrow is ambiguous in an obvious way: people who are struggling may return because they are struggling, not struggle because they return. Still, they see a great many people, and the pattern they describe is one worth checking against.

The honest question is not whether returning is allowed. It is what the next one is expected to do that the last one did not.

If the answer is that the insight was incomplete and there is clearly more to meet, that is a reasonable answer. If the answer is that the feeling has faded and someone wants it back, or that nothing has changed and they are hoping another ceremony will do it for them, then another ceremony is unlikely to help, and the pattern has a name already discussed above.

The unglamorous alternative is a practice. Not a peak, a practice. Something done on ordinary days when nothing is happening, which is where, by every account in this literature, integration actually occurs. The concept analysis makes a point that is genuinely useful here: "the bigger and more transformational the experience, the more incremental the approach to integration may need to be, as they can take time to digest" [1]. The same source observes that integration seems to go better when it is allowed to unfold organically rather than pursued as an overly task-oriented project [1].

Integration is not a task with a completion date.

Researchers make this point directly: experiences continue to acquire different meanings months and years later, and treating integration as something with a definite endpoint is a mistake [4]. Practitioners describe it as a long-term process rather than an event or a brief phase [1]. People who have lived it describe returning to the same experience at different points in their lives and finding something in it they could not have seen before, because they were not yet the person who could see it.

So the honest picture is not the one that psychedelic culture tends to offer. It is not: experience, then insight, then healing.

It is closer to this. Something happened, and it produced material that may be meaningful. That material gets interpreted, carefully, without assuming its truth or dismissing it. Some of it changes how a person behaves and how they treat people. And that, over a long time and unevenly, may produce something lasting.

Each of those arrows can fail. Material can stay uninterpreted. Interpretations can stay unacted on. Actions can fade. The experience and the benefit are not the same thing and are not automatically connected, and what sits between them is the work described in this article.

Which is not a discouraging conclusion, though it may read like one.

It means the part that is still open is the part people have some say over. The ceremony is finished and cannot be redone. What happens next is not finished. The evidence cannot specify the right way to do it, because nobody has done the work of finding out, but it can report what people who have been through this consistently say: that being heard mattered more than being advised, that getting into the body helped more than thinking harder, that community mattered more than expertise, that the people who did best gave themselves some room before returning to full speed, and that most of the difficulty passed.

And it will probably be slower and more ordinary than anyone hoped. The insight arrives all at once. The living of it arrives in small pieces, over years, in the difficult conversations and the morning routines and the moments where someone notices the old pattern starting and chooses, not always successfully, to do something else.

If you experience emotional distress or have medical questions, please seek advice from a qualified health professional.

Every source below was checked directly against publisher records, PubMed or Crossref while this article was written. Nothing is cited from memory, and nothing is cited that could not be verified. Where a claim rests on a small study, an uncontrolled study, a survey, or the opinion of practitioners rather than on a trial, the text says so, because the difference matters more here than in most subjects.

Three kinds of evidence appear, and they are not equivalent. Controlled clinical trials are the strongest and the rarest in this field. Observational, survey and retreat data describe what large numbers of people report, but cannot establish that one thing caused another. Practitioner, traditional and theoretical accounts carry real accumulated knowledge and no statistical weight at all. Most of what is known about integration falls into the second and third categories.

One number deserves a footnote of its own. The large ayahuasca survey reports its headline difficulty figure as 55.4% in its results and tables, and as 55.9% in its own abstract [28]. The source disagrees with itself. This article uses 55.4%, which is the figure its results section and data table support, and the ten individual percentages quoted here match that table exactly.

A few items I could not fully access, and have marked in the text rather than glossed over. Four papers were behind paywalls with no open copy anywhere, so only their published abstracts were read: the systematised review of integration frameworks [3], the review of psychotherapy consensus [6], the review of psychotherapy research [7], and the review of psilocybin protocols [10]. The 2026 chapter on the subacute period [18] is a closed book chapter, read at abstract level. The integration-groups survey [43] is published in a journal whose full text is not open, so only its abstract informed the summary here.

1. Bathje GJ, Majeski E, Kudowor M. Psychedelic integration: an analysis of the concept and its practice. Frontiers in Psychology. 2022;13:824077. doi:10.3389/fpsyg.2022.824077
2. Cowley-Court T, Chenhall R, Sarris J, Bouso JC, Tófoli LF, Opaleye ES, Schubert V, Perkins D. Life after ayahuasca: a qualitative analysis of the psychedelic integration experiences of 1630 ayahuasca drinkers from a global survey. Psychoactives. 2023;2(2):211–232. doi:10.3390/psychoactives2020014
3. Thal SB, Baker P, Marinis J, Wieberneit M, Sharbanee JM, Bruno R, Skeffington PM, Bright SJ. Therapeutic frameworks in integration sessions in substance-assisted psychotherapy: a systematised review. Clinical Psychology & Psychotherapy. 2024;31(1):e2945. doi:10.1002/cpp.2945
4. Greń J, Tylš F, Lasocik M, Kiraly C. Back from the rabbit hole: theoretical considerations and practical guidelines on psychedelic integration for mental health specialists. Frontiers in Psychology. 2023;14:1054692. doi:10.3389/fpsyg.2023.1054692
5. Greń J, Gorman I, Ruban A, Tylš F, Bhatt S, Aixalà M. Call for evidence-based psychedelic integration. Experimental and Clinical Psychopharmacology. 2024;32(2):129–135. doi:10.1037/pha0000684
6. Leone L, McSpadden B, DeMarco A, Enten L, Kline R, Fonzo GA. Psychedelics and evidence-based psychotherapy: a systematic review with recommendations for advancing psychedelic therapy research. Psychiatric Clinics of North America. 2024;47(2):367–398. doi:10.1016/j.psc.2024.02.006
7. Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD. Psychedelic-assisted psychotherapy: where is the psychotherapy research? Psychopharmacology. 2024;241(8):1517–1526. doi:10.1007/s00213-024-06620-x
8. Mele ML, Federici S. Methodological fragmentation and integration priorities in psychedelic-assisted therapy assessment: a scoping review. Frontiers in Psychiatry. 2026;17:1880744. doi:10.3389/fpsyt.2026.1880744
9. Whitfield H, Schepers J, Mason N, Luca M, Kuypers K. Trajectories of psychedelic-assisted change: an observational study of a psilocybin retreat program followed by psychotherapeutic interventions. Journal of Psychedelic Studies. 2026. doi:10.1556/2054.2026.00530
10. Chisamore N, Johnson D, Chen MJQ, et al. Protocols and practices in psilocybin assisted psychotherapy for depression: a systematic review. Journal of Psychiatric Research. 2024;176:77–84. doi:10.1016/j.jpsychires.2024.05.051
11. Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of Psychopharmacology. 2016;30(12):1165–1180. doi:10.1177/0269881116675512
12. Cavarra M, Falzone A, Ramaekers JG, Kuypers KPC, Mento C. Psychedelic-assisted psychotherapy: a systematic review of associated psychological interventions. Frontiers in Psychology. 2022;13:887255. doi:10.3389/fpsyg.2022.887255
13. Shaw J, Yong A, Lee J, Cheng J, Andricioaei A, Wang JY, Zisman-Ilani Y, Bota R. The ethnopharmacological use of mescaline for psychiatric disorders: a systematic review. International Journal of Molecular Sciences. 2026;27(7):3081. doi:10.3390/ijms27073081
14. Zaretsky TG, Jagodnik KM, Barsic R, et al. The psychedelic future of post-traumatic stress disorder treatment. Current Neuropharmacology. 2024;22(4):636–735. doi:10.2174/1570159X22666231027111147
15. Forstmann M, Kettner HS, Sagioglou C, Irvine A, Gandy S, Carhart-Harris RL, Luke D. Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. Journal of Psychopharmacology. 2023;37(1):93–106. doi:10.1177/02698811221146356
16. Cassels BK, Sáez-Briones P. Dark classics in chemical neuroscience: mescaline. ACS Chemical Neuroscience. 2018;9(10):2448–2458. doi:10.1021/acschemneuro.8b00215
17. El-Seedi HR, De Smet PAGM, Beck O, Possnert G, Bruhn JG. Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. Journal of Ethnopharmacology. 2005;101(1–3):238–242. doi:10.1016/j.jep.2005.04.022
18. Evens R, Uyar A, Majić T. Managing psychological challenges in the subacute ("afterglow") window of psychedelic drug effects. Current Topics in Behavioral Neurosciences. 2026;77:355–373. doi:10.1007/7854_2025_612
19. Murphy-Beiner A, Soar K. Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers. Psychopharmacology. 2020;237(4):1161–1169. doi:10.1007/s00213-019-05445-3
20. Sampedro F, de la Fuente Revenga M, Valle M, Roberto N, Domínguez-Clavé E, Elices M, et al. Assessing the psychedelic "after-glow" in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. International Journal of Neuropsychopharmacology. 2017;20(9):698–711. doi:10.1093/ijnp/pyx036
21. Evens R, Schmidt ME, Majić T, Schmidt TT. The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics. Therapeutic Advances in Psychopharmacology. 2023;13. doi:10.1177/20451253231172254
22. Nardou R, Sawyer E, Song YJ, Wilkinson M, Padovan-Hernandez Y, de Deus JL, et al. Psychedelics reopen the social reward learning critical period. Nature. 2023;618(7966):790–798. doi:10.1038/s41586-023-06204-3 (study in mice)
23. Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR. Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports. 2020;10:2214. doi:10.1038/s41598-020-59282-y
24. Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, et al. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Translational Psychiatry. 2021;11:574. doi:10.1038/s41398-021-01706-y
25. Coverdale NS, Cook DJ. Mechanisms of integration in psychedelic-assisted therapy. Journal of Military, Veteran and Family Health. 2023. PMID 42533988
26. Gorman I, Nielson EM, Molinar A, Cassidy K, Sabbagh J. Psychedelic harm reduction and integration: a transtheoretical model for clinical practice. Frontiers in Psychology. 2021;12:645246. doi:10.3389/fpsyg.2021.645246
27. Perkins D, Ruffell SGD, Day K, Pinzon Rubiano D, Sarris J. Psychotherapeutic and neurobiological processes associated with ayahuasca: a proposed model and implications for therapeutic use. Frontiers in Neuroscience. 2023;16:879221. doi:10.3389/fnins.2022.879221
28. Bouso JC, Andión Ó, Sarris JJ, Scheidegger M, Tófoli LF, Opaleye ES, Schubert V, Perkins D. Adverse effects of ayahuasca: results from the Global Ayahuasca Survey. PLOS Global Public Health. 2022;2(11):e0000438. doi:10.1371/journal.pgph.0000438
29. Lutkajtis A, Evans J. Psychedelic integration challenges: participant experiences after a psilocybin truffle retreat in the Netherlands. Journal of Psychedelic Studies. 2023;6(3):211–221. doi:10.1556/2054.2022.00232
30. Evans J, Robinson OC, Argyri EK, Suseelan S, Murphy-Beiner A, McAlpine R, Luke D, Michelle K, Prideaux E. Extended difficulties following the use of psychedelic drugs: a mixed methods study. PLoS One. 2023;18(10):e0293349. doi:10.1371/journal.pone.0293349
31. Argyri EK, Krecké J, Robinson OC, Evans J, Skragge M, Morgan CJA. Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: a qualitative analysis. Harm Reduction Journal. 2025;23(1):24. doi:10.1186/s12954-025-01347-0
32. McGovern HT, Grimmer HJ, Doss MK, Hutchinson BT, Timmermann C, Lyon A, Corlett PR, Laukkonen RE. An integrated theory of false insights and beliefs under psychedelics. Communications Psychology. 2024;2:69. doi:10.1038/s44271-024-00120-6
33. Argyri EK, Evans J, Luke D, Michelle A, Prideaux E, Read T, Sahely A, Robinson OC, et al. Navigating groundlessness: an interview study on dealing with ontological shock and existential distress following psychedelic experiences. PLoS One. 2025;20(5):e0322501. doi:10.1371/journal.pone.0322501
34. Peill JM, Trinci KE, Kettner H, Mertens LJ, Roseman L, Timmermann C, Rosas FE, Lyons T, Carhart-Harris RL. Validation of the Psychological Insight Scale: a new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology. 2022;36(1):31–45. doi:10.1177/02698811211066709
35. Timmermann C, Kettner H, Letheby C, Roseman L, Rosas FE, Carhart-Harris RL. Psychedelics alter metaphysical beliefs. Scientific Reports. 2021;11:22166. doi:10.1038/s41598-021-01209-2
36. Nayak SM, White SH, Hilbert SN, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB. Psychedelic experiences increase mind perception but do not change atheist–believer status: a prospective longitudinal study. Journal of Psychoactive Drugs. 2025;57. doi:10.1080/02791072.2024.2346130
37. Smyth JM. Written emotional expression: effect sizes, outcome types, and moderating variables. Journal of Consulting and Clinical Psychology. 1998;66(1):174–184. doi:10.1037/0022-006X.66.1.174
38. Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychological Bulletin. 2006;132(6):823–865. doi:10.1037/0033-2909.132.6.823
39. Reinhold M, Bürkner PC, Holling H. Effects of expressive writing on depressive symptoms: a meta-analysis. Clinical Psychology: Science and Practice. 2018;25(1):e12224. doi:10.1111/cpsp.12224
40. Robinson OC, Evans J, Luke D, McAlpine R, Sahely A, Fisher A, Sundeman S, Ketzitzidou Argyri E, Murphy-Beiner A, Michelle K, Prideaux E. Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs. Frontiers in Psychology. 2024;15:1369715. doi:10.3389/fpsyg.2024.1369715
41. White MP, Alcock I, Grellier J, Wheeler BW, Hartig T, Warber SL, Bone A, Depledge MH, Fleming LE. Spending at least 120 minutes a week in nature is associated with good health and wellbeing. Scientific Reports. 2019;9(1):7730. doi:10.1038/s41598-019-44097-3
42. Kettner H, Rosas FE, Timmermann C, Kärtner L, Carhart-Harris RL, Roseman L. Psychedelic communitas: intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social connectedness. Frontiers in Pharmacology. 2021;12:623985. doi:10.3389/fphar.2021.623985
43. Modlin NL, McPhee T, Zazon N, Sarang M, et al. Participants' experience of psychedelic integration groups and processes: a qualitative thematic analysis. Psychedelic Medicine. 2025. doi:10.1089/psymed.2024.0027
44. Cheung K, Propes C, Jacobs E, Earp BD, Yaden DB. Psychedelic group-based integration: ethical assessment and initial recommendations. International Review of Psychiatry. 2024;36(8):891–901. doi:10.1080/09540261.2024.2357678
45. Weiss B, Sleep C, Miller JD, Campbell WK. Examining the therapeutic effect of ceremonial ayahuasca on narcissistic personality and antagonistic externalizing in adults. Journal of Personality Disorders. 2023;37(2):131–158. doi:10.1521/pedi.2023.37.2.131
46. Gezon L. Community-based psychedelic integration and social efficacy: an ethnographic study in the Southeastern United States. Journal of Psychedelic Studies. 2024;9(1). doi:10.1556/2054.2024.00381
47. Aday JS, Glynos NG, Baker AK, Pouyan N, Smith T, Barron J, Herberholz M, Kruger DJ, Woolley JD, Boehnke KF. Major life changes following psychedelic use: a retrospective survey among people using psychedelics naturalistically. Scientific Reports. 2026;16. doi:10.1038/s41598-026-48084-3
48. Carlisle NA, Simonsson O, MacCarthy S, Elliott MN, Miller GH, Goldberg SB, Shallcross RA, Hendricks PS. Prevalence, types, and demographic characteristics associated with major life changes following psychedelic use. Scientific Reports. 2026;16. doi:10.1038/s41598-026-37609-5
49. Palitsky R, Kaplan DM, Peacock C, Zarrabi AJ, Maples-Keller JL, Grant GH, et al. Importance of integrating spiritual, existential, religious, and theological components in psychedelic-assisted therapies. JAMA Psychiatry. 2023;80(7):743–749. doi:10.1001/jamapsychiatry.2023.1554
50. Welwood J. Principles of inner work: psychological and spiritual. The Journal of Transpersonal Psychology. 1984;16(1):63–73. (Widely miscited as 1982; the coining passage is on p. 64 of the 1984 paper.)
51. Patel M, Kumar N. "It helps me cope": a meta-ethnographic synthesis on lived experiences of spiritual bypassing. Frontiers in Psychology. 2026;17:1852417. doi:10.3389/fpsyg.2026.1852417
52. Callon C, Williams M, Lafrance A. "Meeting the medicine halfway": ayahuasca ceremony leaders' perspectives on preparation and integration practices for participants. Journal of Humanistic Psychology. 2021. doi:10.1177/00221678211043300
53. Steel, P., Svartdal, F., Thundiyil, T., & Brothen, T. (2018). Examining procrastination across multiple goal stages: A longitudinal study of temporal motivation theory. Frontiers in Psychology, 9, 327. https://doi.org/10.3389/fpsyg.2018.00327
54. Gollwitzer, P. M., & Sheeran, P. (2006). Implementation intentions and goal achievement: A meta-analysis of effects and processes. Advances in Experimental Social Psychology, 38, 69–119.